(Press-News.org) Peer Reviewed | Observational study | People
Researchers at Queen Mary University of London have developed a new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis. The new method provides a more accurate way to predict dementia than memory tests or measurements of brain shrinkage, two commonly used methods for diagnosing dementia.
The team, led by Professor Charles Marshall, developed the predictive test by analysing functional MRI (fMRI) scans to detect changes in the brain’s ‘default mode network’ (DMN). The DMN connects regions of the brain to perform specific cognitive functions and is the first neural network to be affected by Alzheimer’s disease.
The researchers used fMRI scans from over 1,100 volunteers from UK Biobank, a large-scale biomedical database and research resource containing genetic and health information from half a million UK participants, to estimate the effective connectivity between ten regions of the brain that constitute the default mode network.
The researchers assigned each patient with a probability of dementia value based on the extent to which their effective connectivity pattern conforms to a pattern that indicates dementia or a control-like pattern.
They compared these predictions to the medical data of each patient, on record with the UK Biobank. The findings showed that the model had accurately predicted onset of dementia up to nine years before an official diagnosis was made, and with greater than 80% accuracy. In the cases where the volunteers had gone on to develop dementia, it was also found that the model could predict within a two-year margin of error exactly how long it would take that diagnosis to be made.
The researchers also examined whether changes to the DMN might be caused by known risk factors for dementia. Their analysis showed that genetic risk for Alzheimer's disease was strongly associated with connectivity changes in the DMN, supporting the idea that these changes are specific to Alzheimer's disease. They also found that social isolation was likely to increase risk of dementia through its effect on connectivity in the DMN.
Charles Marshall, Professor and Honorary Consultant Neurologist, led the research team within the Centre for Preventive Neurology at Queen Mary’s Wolfson Institute of Population Health. He said: “Predicting who is going to get dementia in the future will be vital for developing treatments that can prevent the irreversible loss of brain cells that causes the symptoms of dementia. Although we are getting better at detecting the proteins in the brain that can cause Alzheimer’s disease, many people live for decades with these proteins in their brain without developing symptoms of dementia. We hope that the measure of brain function that we have developed will allow us to be much more precise about whether someone is actually going to develop dementia, and how soon, so that we can identify whether they might benefit from future treatments."
Samuel Ereira, lead author and Academic Foundation Programme Doctor at the Centre for Preventive Neurology, Wolfson Institute of Population Health, said: “Using these analysis techniques with large datasets we can identify those at high dementia risk, and also learn which environmental risk factors pushed these people into a high-risk zone. Enormous potential exists to apply these methods to different brain networks and populations, to help us better understand the interplays between environment, neurobiology and illness, both in dementia and possibly other neurodegenerative diseases. fMRI is a non-invasive medical imaging tool, and it takes about 6 minutes to collect the necessary data on an MRI scanner, so it could be integrated into existing diagnostic pathways, particularly where MRI is already used.”
Hojjat Azadbakht, CEO of AINOSTICS (an AI company collaborating with world-leading research teams to develop brain imaging approaches for the early diagnosis of neurological disorders) said: "The approach developed has the potential to fill an enormous clinical gap by providing a non-invasive biomarker for dementia. In the study published by the team at QMUL, they were able to identify individuals who would later develop Alzheimer’s disease up to 9 years before they received a clinical diagnosis. It is during this pre-symptomatic stage that emerging disease-modifying treatments are likely to offer the most benefit for patients."
ENDS
NOTES TO EDITORS
Contact:
Sophia Prout
Faculty Communications Manager – Medicine and Dentistry
Queen Mary University of London
Email: s.prout@qmul.ac.uk or press@qmul.ac.uk
Paper details:
Charles R. Marshall, Sam Ereira, Sheena Wates, Adeel Razi. “Early detection of dementia with default-mode network effective connectivity.” Published in Nature Mental Health.
DOI: 10.1038/s44220-024-00259-5
Available after publication at: https://www.nature.com/articles/s44220-024-00259-5
Under strict embargo until 10AM (BST) ON THURSDAY 6 JUNE 2024.
A copy of the paper is available upon request.
Funding information:
UKB data access was funded by a grant from the Tom and Sheila Springer Charity.
Conflicts of Interest Disclosures:
None.
About Queen Mary
www.qmul.ac.uk
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
Our reformer heritage informs our conviction that great ideas can and should come from anywhere. It’s an approach that has brought results across the globe, from the communities of east London to the favelas of Rio de Janeiro.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
END
First-of-its-kind test can predict dementia up to nine years before diagnosis
2024-06-06
ELSE PRESS RELEASES FROM THIS DATE:
Popular chatbot is a politically left-leaning EU supporter
2024-06-06
With the European Parliament elections now underway, millions of EU citizens are finalizing their decisions about which political party best represents their views.
But anyone using LlamaChat, one of the major new AI chatbots, is very likely to be confronted with biased answers. It turns out that the large language model developed by Meta, upon which LlamaChat is based, has clear political leanings. This has been demonstrated in a new study from the University of Copenhagen in which Department of Computer Science researchers examined the language model's knowledge of political groups in the European Parliament. Moreover, they tested LlamaChat’s ...
Doctors advise caution as energy drinks may trigger life-threatening cardiac arrhythmias in patients with genetic heart diseases
2024-06-06
Philadelphia, June 6, 2024 – A new study in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier, examined the potential dangers of consuming energy drinks for patients with genetic heart diseases. A cohort of 144 sudden cardiac arrest survivors was examined at Mayo Clinic, of which seven patients (5%) had consumed one or more energy drinks in close proximity to their cardiac ...
Only around half of individuals disclose or believe they should reveal having an STI prior to sexual intercourse, research to-date suggests
2024-06-06
A review of research to-date reveals the complex nature of revealing a diagnosis of a sexually transmitted infection (STI) to a partner ahead of engaging in sexual activity.
With individuals experiencing a variety of feelings and emotions related to the prospect of disclosure, the research shows that only around half or fewer individuals felt able to disclose their diagnosis to a partner before sexual engagement.
Peer-reviewed results, published today in The Journal of Sex Research, also show a similar number of people believed they should have to disclose having a STI to a partner prior to engaging in sexual intercourse.
In order ...
Climate crisis puts Australia’s ski industry on slippery slope, but not all hope is lost
2024-06-06
Australia’s ski industry is at risk of major disruptions and shorter seasons if the current level of climate pollution continues, according to new modelling from Protect Our Winters Australia (POW) and The Australian National University (ANU).
The report found the average ski season across all resorts in Australia will be 44 days shorter by 2050 under a mid-greenhouse gas emissions scenario and 55 days shorter under a high-emissions scenario.
It also shows that despite a dramatic decline in snowfall under mid- and high-emissions scenarios, the ...
Tiny roundworms carve out unique parasitic niche inside pseudoscorpion’s protective covering
2024-06-06
CORVALLIS, Ore. – The early worm gets the arachnid, fossil research by an Oregon State University scientist has shown.
In a parasitic first, a Baltic amber specimen has revealed that millions of years ago tiny worms known as nematodes were living inside of and feeding on the outer protective layer of pseudoscorpions.
“This is very strange,” said George Poinar Jr., who has a courtesy appointment in the OSU College of Science. “No other invertebrate-associated nematodes are known to have this detailed habit.”
Findings were published in Historical Biology.
Pseudoscorpions are a highly diverse lineage of arachnid, said Poinar, an international expert in ...
Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns
2024-06-06
Drugs like Ozempic, Wegovy and Mounjaro have been around for years, but they’ve recently been making headlines due to a rise in popularity as weight loss agents. They all belong to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1RAs), which mimic a hormone (GLP-1) in the body that helps control insulin and blood glucose levels and promotes feelings of satiety.
These drugs are extremely effective for blood glucose control and weight management, which, combined with their relatively limited side effect profile, makes them ...
How a protein component of nuclear pore complexes regulates development of blood cells and may contribute to myeloid disorders
2024-06-06
Nuclear pore complexes (NPCs) are channels composed of multiple proteins that ferry molecules in and out of the nucleus, regulating many critical cellular functions, such as gene expression, chromatin organization and RNA processes that influence cell survival, proliferation, and differentiation.
In recent years, new studies, including work by Maximiliano D’Angelo, Ph.D., associate professor in the Cancer Metabolism and Microenvironment Program at Sanford Burnham Prebys, have noted that NPCs in cancer cells are different, but how ...
Drug used to treat eczema may provide relief for patients with intensely itchy skin diseases
2024-06-06
A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study published in JAMA Dermatology. The drug, abrocitinib, was found to cause minimal side effects during a small 12-week study led by University of Maryland School of Medicine (UMSOM) researchers. It was beneficial for those with an itching disease called prurigo nodularis as well as for those with chronic pruritus of unknown origin, a condition that causes chronic unexplainable itching symptoms.
“Very ...
The problem with prison abolition? Misunderstanding it
2024-06-06
“Approximately one in seventy working people in the United States are employed by either the police or departments of corrections.” In recent years, and in particular, in the aftermath of the Black Lives Matter protests of 2020, activists have focused renewed attention on the role of prisons in the United States. Thinkers like Angela Davis have articulated the ways in which the prison-industrial complex serves the interest of an oppressive state by reinforcing race and class hierarchies and extracting value from its incarcerated population. But despite this surge of interest ...
The Lancet Psychiatry: One in six people who stop antidepressants will experience discontinuation symptoms as a direct result, finds most comprehensive study to date
2024-06-06
Peer-reviewed / Systematic review & meta-analysis / People
Embargoed access to the paper and linked comment and contact details for authors are available in Notes to Editors at the end of the release.
The first meta-analysis on the incidence of antidepressant discontinuation symptoms includes data from over 20,000 patients gathered from 79 randomised controlled trials and observational studies.
Overall, approximately one in three patients reported a discontinuation ...